Moderna is also connected to mRNA firms that Gates has invested in. Latypova said these investments appeared “strange” — until the COVID-19 pandemic.
“I think in general Gates has been obsessed with the idea of vaccination, which, for a long time, was not a good business investment … So it’s at a minimum strange that he pursued vaccinations, especially in the Third World, so zealously. It didn’t make financial sense until COVID,” Latypova said.
For instance, Gates maintains significant holdings in Danaher Corporation, a life sciences healthcare company. The Gates Foundation first invested in Danaher in 2022 and, as of the third quarter of 2023, these investments totaled $92.54 million.
In 2021, Danaher purchased Aldevron, a company that manufactures “high-quality plasmid DNA, mRNA, and proteins” — and that produced the DNA used in Moderna’s COVID-19 vaccines.
Last year, Aldevron announced the expansion of its “mRNA production capabilities to include lipid nanoparticle (LNP) encapsulation.”
This is not the only connection between Aldevron — which touts the benefits of mRNA on its blog — and Moderna. In 2021, the two companies announced an “expanded partnership for mRNA vaccine and therapeutic pipeline,” while Kenneth Chien, Ph.D., co-founder of Moderna, was an Aldevron board member.
The Gates Foundation may have been linked to Aldevron as early as 2017 when the foundation and Aldevron both supported research on modified viruses published in the Journal of Virology.
Persecution Live 